Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract
Journal of Veterinary Diagnostic Investigation · 2026
DOI: 10.1177/10406387251362820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Diagnostic Investigation, 2026. Verfasst von Anke Beermann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Livestock Sciences, Soil Sciences and Crop Sciences (FiBL), Research Institute of Organic Agriculture, Frick, Switzerland. Hauptthemen laut MEDLINE: Horse Diseases, MicroRNAs, Plant Extracts, Sarcoidosis. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Rudolf Steiner Fund for Scientific Research e.V., Nuremberg, Germany, Stiftung Pro Pferd, Zurich, Switzerland, The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland.
Abstract (Originalsprache)
We investigated microRNAs (miRNAs) as potential prognostic biomarkers for equine sarcoid (ES) disease. In a breed-, age-, and sex-matched case-controlled study involving 45 ES-affected and 15 control horses, we assessed the diagnostic, prognostic, and theragnostic value of 3 miRNAs (eca-miR-127, eca-miR-379, eca-miR-432) in horses treated with European mistletoe ( Viscum album ) extract versus placebo. Whole-blood miRNA concentrations were measured using reverse-transcription quantitative real-time PCR (RT-qPCR) at 3 different times. We found that eca-miR-432 expression was lower in ES-affected (median = −1.93; 95% CI: −2.03 to −.86) compared to control (median = −1.71; 95% CI: −1.92 to −1.6) horses ( p = 0.03, r = 0.3; 95% CI: 0.024–0.57) with a median difference of −1.93 versus −1.71, respectively. The ROC curve analysis indicated an area under the curve of 0.71 (95% CI: 0.51–0.84; p = 0.005) with a sensitivity of 74% (95% CI: 61–88%) and a specificity of 73% (95% CI: 39–94%) to diagnose ES. However, none of the miRNAs evaluated had prognostic potential or significant changes in expression following treatment. Additionally, miRNA expression was not influenced by breed, sex, or season. Although whole-blood eca-miR-432 had moderate diagnostic potential for ES, identifying prognostic miRNA biomarkers for ES remains a challenge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Livestock Sciences, Soil Sciences and Crop Sciences (FiBL), Research Institute of Organic Agriculture, Frick, Switzerland.
- Department of Zoonoses, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
- Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine (ISME), Vetsuisse Faculty, University of Bern, Bern, Switzerland.
ORCID-Profile: Anke Beermann, Eman Hamza, Sonja Reinhard, Christoph Koch, Thomas Oberhänsli, Lucia Unger
Förderung
- Rudolf Steiner Fund for Scientific Research e.V., Nuremberg, Germany
- Stiftung Pro Pferd, Zurich, Switzerland
- The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland
- The Swiss Veterinary Association for Alternative and Complementary Medicine (camvet.ch), Bern, Switzerland
- Society of Cancer Research, Arlesheim, Switzerland
- Iscador AG, Arlesheim, Switzerland
Zitieren
APA
Beermann, A., Hamza, E., Reinhard, S., Koch, C., Oberhänsli, T., & Unger, L. (2026). Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract. Journal of Veterinary Diagnostic Investigation. https://doi.org/10.1177/10406387251362820
Vancouver
Beermann A, Hamza E, Reinhard S, Koch C, Oberhänsli T, Unger L. Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract. Journal of Veterinary Diagnostic Investigation. 2026. doi:10.1177/10406387251362820
BibTeX
@article{Beermann2026,
author = {Beermann, Anke and Hamza, Eman and Reinhard, Sonja and Koch, Christoph and Oberhänsli, Thomas and Unger, Lucia},
title = {Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract},
journal = {Journal of Veterinary Diagnostic Investigation},
year = {2026},
doi = {10.1177/10406387251362820}
}
EUVIMED